,dataset_name,cell_type,cell_type_ontology_id,donor_id,sex,race,development_stage,count,percentage
0,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",T cell,CL:0000084,KR_SGI_H165,female,Korean,27-year-old human stage,89,4.143389199255121
1,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",erythrocyte,CL:0000232,KR_SGI_H165,female,Korean,27-year-old human stage,4,0.186219739292365
2,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",platelet,CL:0000233,KR_SGI_H165,female,Korean,27-year-old human stage,37,1.722532588454376
3,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",B cell,CL:0000236,KR_SGI_H165,female,Korean,27-year-old human stage,14,0.6517690875232774
4,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",monocyte,CL:0000576,KR_SGI_H165,female,Korean,27-year-old human stage,40,1.86219739292365
5,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",natural killer cell,CL:0000623,KR_SGI_H165,female,Korean,27-year-old human stage,12,0.5586592178770949
6,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","CD4-positive, alpha-beta T cell",CL:0000624,KR_SGI_H165,female,Korean,27-year-old human stage,47,2.188081936685289
7,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","CD8-positive, alpha-beta T cell",CL:0000625,KR_SGI_H165,female,Korean,27-year-old human stage,4,0.186219739292365
8,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",plasmacytoid dendritic cell,CL:0000784,KR_SGI_H165,female,Korean,27-year-old human stage,2,0.0931098696461825
9,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",mature B cell,CL:0000785,KR_SGI_H165,female,Korean,27-year-old human stage,8,0.37243947858473
10,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",memory B cell,CL:0000787,KR_SGI_H165,female,Korean,27-year-old human stage,124,5.772811918063315
11,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",naive B cell,CL:0000788,KR_SGI_H165,female,Korean,27-year-old human stage,12,0.5586592178770949
12,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","CD8-positive, alpha-beta cytotoxic T cell",CL:0000794,KR_SGI_H165,female,Korean,27-year-old human stage,92,4.283054003724395
13,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",gamma-delta T cell,CL:0000798,KR_SGI_H165,female,Korean,27-year-old human stage,30,1.3966480446927374
14,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",regulatory T cell,CL:0000815,KR_SGI_H165,female,Korean,27-year-old human stage,11,0.5121042830540037
15,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","naive thymus-derived CD4-positive, alpha-beta T cell",CL:0000895,KR_SGI_H165,female,Korean,27-year-old human stage,394,18.34264432029795
16,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","naive thymus-derived CD8-positive, alpha-beta T cell",CL:0000900,KR_SGI_H165,female,Korean,27-year-old human stage,322,14.990689013035382
17,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","central memory CD4-positive, alpha-beta T cell",CL:0000904,KR_SGI_H165,female,Korean,27-year-old human stage,217,10.1024208566108
18,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","effector memory CD4-positive, alpha-beta T cell",CL:0000905,KR_SGI_H165,female,Korean,27-year-old human stage,66,3.072625698324022
19,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","CD8-positive, alpha-beta memory T cell",CL:0000909,KR_SGI_H165,female,Korean,27-year-old human stage,32,1.48975791433892
20,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","CD4-positive, alpha-beta cytotoxic T cell",CL:0000934,KR_SGI_H165,female,Korean,27-year-old human stage,14,0.6517690875232774
21,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","CD16-negative, CD56-bright natural killer cell, human",CL:0000938,KR_SGI_H165,female,Korean,27-year-old human stage,31,1.4432029795158288
22,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","CD16-positive, CD56-dim natural killer cell, human",CL:0000939,KR_SGI_H165,female,Korean,27-year-old human stage,159,7.402234636871509
23,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",mucosal invariant T cell,CL:0000940,KR_SGI_H165,female,Korean,27-year-old human stage,61,2.839851024208566
24,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",CD14-positive monocyte,CL:0001054,KR_SGI_H165,female,Korean,27-year-old human stage,267,12.430167597765362
25,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","CD14-low, CD16-positive monocyte",CL:0002396,KR_SGI_H165,female,Korean,27-year-old human stage,31,1.4432029795158288
26,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",CD1c-positive myeloid dendritic cell,CL:0002399,KR_SGI_H165,female,Korean,27-year-old human stage,28,1.303538175046555
